ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 95 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $751,026 | +19.0% | 37,439 | +28.6% | 0.00% | 0.0% |
| Q3 2022 | $631,000 | -59.0% | 29,112 | -46.8% | 0.00% | -50.0% |
| Q2 2022 | $1,538,000 | +59.0% | 54,745 | +161.2% | 0.00% | +100.0% |
| Q1 2022 | $967,000 | -36.4% | 20,959 | +15.8% | 0.00% | 0.0% |
| Q4 2021 | $1,521,000 | -58.1% | 18,092 | -66.8% | 0.00% | -66.7% |
| Q3 2021 | $3,628,000 | +20.8% | 54,438 | -3.6% | 0.00% | 0.0% |
| Q2 2021 | $3,003,000 | +212.2% | 56,454 | +154.6% | 0.00% | +200.0% |
| Q1 2021 | $962,000 | -59.1% | 22,171 | -51.0% | 0.00% | -50.0% |
| Q4 2020 | $2,352,000 | +801.1% | 45,287 | +466.6% | 0.00% | – |
| Q3 2020 | $261,000 | -78.2% | 7,993 | -67.9% | 0.00% | -100.0% |
| Q2 2020 | $1,197,000 | – | 24,935 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 300,434 | $25,254,000 | 7.21% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 | $220,944,000 | 6.56% |
| Avidity Partners Management LP | 2,715,000 | $228,223,000 | 4.84% |
| Matrix Capital Management Company, LP | 4,349,279 | $365,600,000 | 4.07% |
| Affinity Asset Advisors, LLC | 117,500 | $9,877,000 | 3.59% |
| Integral Health Asset Management, LLC | 120,000 | $10,087,000 | 2.79% |
| Ghost Tree Capital, LLC | 80,000 | $6,725,000 | 2.41% |
| Ikarian Capital, LLC | 191,140 | $16,067,000 | 2.39% |
| Tri Locum Partners LP | 23,632 | $1,987,000 | 0.78% |
| Eventide Asset Management | 529,000 | $44,468,000 | 0.57% |